logo
Your phone habits may be exposing your children to mature content, new study finds

Your phone habits may be exposing your children to mature content, new study finds

CNN04-02-2025
You might not think twice about spending extended time on your phone around your children, but a new study suggests that parents' screen-time habits are associated with children accessing more age-inappropriate content.
Parental screen usage in front of children and family rules around devices are significantly linked to higher odds of kids watching R-rated movies and playing mature-rated video games, according to a new study published Tuesday in the journal BMC Pediatrics.
'We wanted to explore parent rules and adolescents' exposure to mature content because there's a lack of research to guide parents of young adolescents on media use,' said lead study author Dr. Jason Nagata, associate professor of pediatrics at the University of California, San Francisco School of Medicine, via email. 'While the American Academy of Pediatrics provides general recommendations for ages 5 to 18, young adolescents are at a unique developmental stage — they're not little kids anymore, but they're also not fully independent teens.'
Nagata and other researchers analyzed data from the Adolescent Brain Cognitive Development (ABCD) Study, including more than 10,000 adolescents aged 12 to 13.
Parents responded to a 14-item questionnaire, rating their agreement with statements such as, 'I try to limit how much I use a screen-based device when I am with my child' on a scale from 1 (strongly disagree) to 4 (strongly agree).
Adolescents also self-reported their exposure to mature content by answering two questions, 'How often do you watch R-rated movies?' and 'How often do you play mature-rated video games?' on a scale from 0 (never) to 3 (all the time).
The study found that with each unit increase in parental screen use — based on the 1 to 4 scale — there was an 11% increase in the likelihood of children engaging with both mature video games and R-rated movies.
'This (study) offers strong encouragement for us as parents to keep on monitoring and limiting our kids' use of screens, even when doing so is difficult and unpleasant because we get a lot of pushback from our kids,' said CNN contributor Dr. Kara Alaimo, associate professor of communication at Fairleigh Dickinson University in New Jersey and author of 'Over the Influence,' via email.
Frequent screen use during meals and high levels of bedroom screentime in adolescents were also notably associated with increased exposure to mature content, according to the study.
How parents can limit screen time
For parents uncertain about navigating their child's screen time, a good starting point is modeling healthy device habits.
Children tend to mirror their parents' behavior, so if adults frequently use their phones, adolescents will be inclined to do the same.
'Parents should practice what they preach,' Nagata said. 'If parents make a family rule to not text at the dinner table, they should follow it.'
Alaimo encourages parents to reflect on their own phone usage around their kids, asking whether the activities they do on their phones are truly meaningful or mindless scrolling that provides little value.
While she acknowledges it's not always possible, she also suggests that parents try to spend time on their devices when their children are at school or asleep to maximize quality in-person family time.
If parents take the time to initiate a conversation around efforts to manage their personal screen time, it can provide more thoughtful and relatable examples for kids to follow, Alaimo said.
Navigating screen-time boundaries with your child
Nagata emphasized that adolescent bedroom screen use had the strongest correlation with exposure to mature content. To effectively limit access to inappropriate media, families should establish clear screen rules during meals and before bedtime, he added.
The American Academy of Pediatrics recommends creating a family media plan to set specific, practical guidelines tailored to each household.
To initiate device guidelines, parents should promote frequent conversations around appropriate phone use, which can include eliminating any screens during certain times of the day.
Since every family's media plan will differ, Nagata said it's important for parents to adjust screen-time rules as children grow. That may include reassessing what content is appropriate, which devices are used and how much time is spent on screens.
The study also found that using screen time as a punishment often led children to seek out more mature content, which Nagata attributed to adolescents who are craving independence and may react negatively to restrictive measures.
'I've seen that when kids fear that their parents will take away their screens, it can discourage them from coming to their parents when they end up in trouble online and need help — for example, if they're being blackmailed for money,' Alaimo said. 'Tempting though it can be for all of us, this study gives parents another reason to think twice before wielding such punishments.'
However, children who were rewarded with screen time tended to consume less mature media. Nagata suggests that positive reinforcement strategies with screens can be effective in encouraging other healthy device habits.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds
Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds

Yahoo

timean hour ago

  • Yahoo

Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds

Scientists have identified two natural compounds that could help reverse ageing in brain cells and remove harmful protein buildup, raising hopes for a non-drug approach to treat Alzheimer's disease. The research, published in the journal GeroScience, identifies two natural compounds, nicotinamide – a form of vitamin B3 – and an antioxidant found in green tea called epigallocatechin gallate, which help restore a key molecule that fuels energy production in brain cells. Researchers found that nerve cells treated with these compounds not only experienced reversal of age-related decline but also an enhanced ability to clear away amyloid protein clusters, a hallmark feature of Alzheimer's. 'As people age, their brains show a decline in neuronal energy levels, which limits the ability to remove unwanted proteins and damaged components,' said Gregory Brewer, lead author of the study. 'We found that restoring energy levels helps neurons regain this critical cleanup function,' Dr Brewer said. Researchers used a fluorescent molecule to track live guanosine triphosphate levels in neurons from aged mice showing signs of Alzheimer's. Scientists found that the levels of energy-rich molecules GTP declined with age – particularly in the cells' mitochondria – leading to impaired elimination of cells with damaged components in a process called autophagy. While it is known that autophagy, the cell's natural clean-up process, plays a key role in maintaining the health of tissues and organs, what part of ageing causes impairment in this process remains elusive. When aged nerve cells were treated for just 24 hours with the study molecules nicotinamide and epigallocatechin gallate, the GTP levels were restored to levels typically seen in younger cells. 'Our results reveal age and AD-related neuronal GTP energy deficits that impair autophagy,' scientists wrote. The molecules also improved energy metabolism within these cells, as well as efficient clearance of amyloid beta clusters. 'By supplementing the brain's energy systems with compounds that are already available as dietary supplements, we may have a new path toward treating age-related cognitive decline and Alzheimer's disease,' Dr Brewer said. 'This study highlights GTP as a previously under-appreciated energy source driving vital brain functions,' he added. Researchers cautioned that more studies are required to find the best way to administer the compounds as treatment. A recent study also showed that nicotinamide was not very effective when taken orally due to its inactivation in the bloodstream. However, the findings point to promising strategies to rescue neurons in the brain's hippocampus from energy deficits related to ageing and Alzheimer's disease, researchers say. Solve the daily Crossword

Rivaroxaban or Combo Therapy: A Winner for All Ages?
Rivaroxaban or Combo Therapy: A Winner for All Ages?

Medscape

time3 hours ago

  • Medscape

Rivaroxaban or Combo Therapy: A Winner for All Ages?

TOPLINE: In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy reduced the risks for major cardiovascular events (MACE) and major bleeding across all adult age groups. METHODOLOGY: Researchers performed a post hoc analysis of data from the AFIRE trial, conducted in Japan, to assess the age-stratified effects of rivaroxaban monotherapy vs treatment with rivaroxaban plus an antiplatelet agent. The analysis included 2215 patients (mean age, 74.3 years; 79.1% men) with AF and stable CAD more than 1 year after revascularization or angiographically confirmed CAD that did not need revascularization. Patients were randomly assigned to 10 mg or 15 mg of rivaroxaban monotherapy, depending on creatinine clearance, or combination therapy involving rivaroxaban plus aspirin or a P2Y12 inhibitor (at the physician's discretion). The patients were stratified into four age groups: younger than 70 years, 70-74 years, 75-79 years, and 80 years or older. The primary efficacy endpoint was MACE, defined as a composite of stroke, myocardial infarction, systemic embolism, unstable angina requiring revascularization, or death; the primary safety endpoint was major bleeding. The patients were followed for up to 45 months. TAKEAWAY: Across the age spectrum, rivaroxaban alone matched combination therapy for reducing the risks for MACE and major bleeding. However, rivaroxaban monotherapy, compared with combination therapy, was associated with a more pronounced reduction in the risk for MACE among patients aged 80 years or older (hazard ratio [HR], 0.61; 95% CI, 0.40-0.93) and a more pronounced reduction in the risk for major bleeding among those younger than 70 years (HR, 0.23; 95% CI, 0.06-0.79). IN PRACTICE: 'Although the present study did not clarify the factors involved, it is important to reaffirm that rivaroxaban monotherapy effectively reduces net adverse clinical events, which comprehensively include both thrombotic and hemorrhagic events, across a wide age range, even in older patients,' the researchers reported. SOURCE: This study was led by Junichi Yamaguchi, MD, PhD, of the Department of Cardiology at Tokyo Women's Medical University in Tokyo, Japan. It was published online on August 13, 2025, in JAMA Cardiology. LIMITATIONS: The open-label design of the trial may have introduced bias. As a post hoc analysis, this study was underpowered, and differences between the two arms may have been missed due to small sample size. The antiplatelet agent was chosen by the treating physician and was not standardized. DISCLOSURES: This study received support from the Japan Cardiovascular Research Foundation through a contract with Bayer Yakuhin, Ltd. Several authors reported receiving grants, personal fees, and endowments from multiple sources, including Bayer, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Abbott, among others. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds
Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds

Yahoo

time3 hours ago

  • Yahoo

Natural compound found in popular hot drink could protect brain against Alzheimer's, study finds

Scientists have identified two natural compounds that could help reverse ageing in brain cells and remove harmful protein buildup, raising hopes for a non-drug approach to treat Alzheimer's disease. The research, published in the journal GeroScience, identifies two natural compounds, nicotinamide – a form of vitamin B3 – and an antioxidant found in green tea called epigallocatechin gallate, which help restore a key molecule that fuels energy production in brain cells. Researchers found that nerve cells treated with these compounds not only experienced reversal of age-related decline but also an enhanced ability to clear away amyloid protein clusters, a hallmark feature of Alzheimer's. 'As people age, their brains show a decline in neuronal energy levels, which limits the ability to remove unwanted proteins and damaged components,' said Gregory Brewer, lead author of the study. 'We found that restoring energy levels helps neurons regain this critical cleanup function,' Dr Brewer said. Researchers used a fluorescent molecule to track live guanosine triphosphate levels in neurons from aged mice showing signs of Alzheimer's. Scientists found that the levels of energy-rich molecules GTP declined with age – particularly in the cells' mitochondria – leading to impaired elimination of cells with damaged components in a process called autophagy. While it is known that autophagy, the cell's natural clean-up process, plays a key role in maintaining the health of tissues and organs, what part of ageing causes impairment in this process remains elusive. When aged nerve cells were treated for just 24 hours with the study molecules nicotinamide and epigallocatechin gallate, the GTP levels were restored to levels typically seen in younger cells. 'Our results reveal age and AD-related neuronal GTP energy deficits that impair autophagy,' scientists wrote. The molecules also improved energy metabolism within these cells, as well as efficient clearance of amyloid beta clusters. 'By supplementing the brain's energy systems with compounds that are already available as dietary supplements, we may have a new path toward treating age-related cognitive decline and Alzheimer's disease,' Dr Brewer said. 'This study highlights GTP as a previously under-appreciated energy source driving vital brain functions,' he added. Researchers cautioned that more studies are required to find the best way to administer the compounds as treatment. A recent study also showed that nicotinamide was not very effective when taken orally due to its inactivation in the bloodstream. However, the findings point to promising strategies to rescue neurons in the brain's hippocampus from energy deficits related to ageing and Alzheimer's disease, researchers say. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store